Daily News Podcast

Shifting Part B to D: Who saves?

Publish date: February 5, 2019

 

A shift in Medicare drug coverage from Part B to Part D might save the government money, but might cost patients. Also today, there’s no single treatment for fibromyalgia, obesity-related cancers are increasing in younger adults, and pregnancy problems predict cardiovascular future.

Amazon Alexa

Apple Podcasts

Google Podcasts

Spotify

Recommended Reading

Decreased insulin clearance and insulin resistance
MDedge Neurology
AHA reports statins are safe
MDedge Neurology
ACA in peril after Texas ruling
MDedge Neurology
Ray Barfield Part II: Philosophy and Medicine
MDedge Neurology
Dermatologic comorbidities of atopic dermatitis
MDedge Neurology
Breast cancer study: No link between soy, all-cause mortality
MDedge Neurology
Too much, too little sleep linked to atherosclerosis
MDedge Neurology
Courts stop contraceptive mandate
MDedge Neurology
The effects of delayed contraception
MDedge Neurology
Podcasting, burnout, oncology: Dr. David Henry
MDedge Neurology